A carregar...
Oxaliplatin-Based Doublets Versus Cisplatin or Carboplatin-Based Doublets in the First-Line Treatment of Advanced Nonsmall Cell Lung Cancer
The efficacy and toxicity of oxaliplatin-based versus carboplatin/cisplatin-based doublets in patients with previously untreated nonsmall cell lung cancer (NSCLC) have been compared. We searched published randomized controlled trials of oxaliplatin-based or carboplatin/cisplatin-based medications fo...
Na minha lista:
Publicado no: | Medicine (Baltimore) |
---|---|
Main Authors: | , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Wolters Kluwer Health
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4504603/ https://ncbi.nlm.nih.gov/pubmed/26166081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001072 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|